Hepatitis C is a worldwide issue with an
estimated three million infected people in the United States alone.
Treatment for hepatitis C is difficult, with sometimes severe side
effects, and medications are expensive, limiting treatment to those who
can afford it. However, recent advances in clinical trials and changes
by drug manufacturers could change the way hepatitis C is treated in the
Labels: Overview of current state of treatments